Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Recombinant human thrombopoietin, rhTPO, TPO + [1] |
Target |
Mechanism TPO receptor agonists(Thrombopoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BR (01 Jan 2015), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Thrombocytopenia | BR | 01 Jan 2015 |
Not Applicable | - | Group A (15,000U) | tmwejadtpd(dynoajjddk) = Treatment-related adverse events were reported in 6 (9.8%) and 6 (13.6%) patients in the group A and group B, respectively, all being mild and transient in nature cniplihcal (dpsziisgbe ) View more | - | 09 Jul 2022 | ||
Group B (30,000U) |